Advertisement
UK markets closed
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • CRUDE OIL

    79.48
    +0.49 (+0.62%)
     
  • GOLD FUTURES

    2,343.60
    +21.30 (+0.92%)
     
  • DOW

    39,383.61
    +327.22 (+0.84%)
     
  • Bitcoin GBP

    49,725.61
    +142.97 (+0.29%)
     
  • CMC Crypto 200

    1,340.09
    +39.99 (+3.07%)
     
  • NASDAQ Composite

    16,341.45
    +38.70 (+0.24%)
     
  • UK FTSE All Share

    4,558.37
    +14.13 (+0.31%)
     

AstraZeneca’s Respiratory Segment in 3Q17

AstraZeneca’s (AZN) Respiratory segment is one of its key growth platforms. For 3Q17, the segment's revenues fell 2% at constant exchange rates to ~$1.1 billion.